Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. - North ML; Walker TJ; Steacy LM; Hobsbawn BG; Allan RJ; Hackman F; Sun X; Day AG; Ellis AK (Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2014)